We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.51%
AUM
$531M
AUM Growth
-$8.26M
Cap. Flow
-$3.33M
Cap. Flow %
-0.63%
Top 10 Hldgs %
23%
Holding
170
New
2
Increased
45
Reduced
60
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 22.94%
2 Technology 13.75%
3 Industrials 12.06%
4 Consumer Staples 10.11%
5 Energy 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
151
Thermo Fisher Scientific
TMO
$213B
$234K 0.04%
1,800
-175
-9% -$22.8K
ITRI icon
152
Itron
ITRI
$4.36B
$221K 0.04%
6,405
M icon
153
Macy's
M
$6.53B
$221K 0.04%
3,270
PX
154
DELISTED
Praxair Inc
PX
$218K 0.04%
1,823
EQR icon
155
Equity Residential
EQR
$24.9B
$203K 0.04%
2,900
-50
-2% -$3.71K
KOS icon
156
Kosmos Energy
KOS
$1.6B
$169K 0.03%
20,000
CKSW
157
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$156K 0.03%
12,400
SJT
158
San Juan Basin Royalty Trust
SJT
$117M
$128K 0.02%
11,905
-500
-4% -$5.54K
EPM icon
159
Evolution Petroleum
EPM
$132M
$119K 0.02%
18,000
GCAP
160
DELISTED
Gain Capital Holdings, Inc.
GCAP
$106K 0.02%
11,042
JAGX icon
161
Jaguar Health
JAGX
$4.91M
0
MBI icon
162
MBIA
MBI
$261M
$63K 0.01%
10,500
GBIM
163
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
$47K 0.01%
18,056
GIS icon
164
General Mills
GIS
$19.1B
-3,650
Closed -$207K
IRWD icon
165
Ironwood Pharmaceuticals
IRWD
$696M
-33,926
Closed -$455K
KPTI icon
166
Karyopharm Therapeutics
KPTI
$43.5M
-2,599
Closed -$1.19M
MAT icon
167
Mattel
MAT
$4.38B
-14,845
Closed -$339K
ESRX
168
DELISTED
Express Scripts Holding Company
ESRX
-2,599
Closed -$226K
PWRD
169
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
-19,842
Closed -$369K
DTSI
170
DELISTED
DTS, Inc.
DTSI
-5,928
Closed -$202K

Similar funds

Woodstock Corp's Q2 2015 Portfolio in Review

As of Q2 2015, Woodstock Corp held 170 positions worth $531M, down 1.5% from $539M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Woodstock Corp's Q2 2015 filing shows 2 new, 45 increased, 60 reduced and 7 closed positions. Its largest new stake was Neurocrine Biosciences: 19,955 shares worth $953K. The largest sale was Karyopharm Therapeutics, an estimated $1.19M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q2 2015 buy was Neurocrine Biosciences: 19,955 shares worth $953K.
  • Woodstock Corp added most to Southwestern Energy Company in Q2 2015, an estimated $1.47M increase.
  • Woodstock Corp's biggest Q2 2015 reduction was ExxonMobil, cutting an estimated $585K.
  • Woodstock Corp fully exited Karyopharm Therapeutics in Q2 2015, selling an estimated $1.19M.
  • Woodstock Corp's ten largest holdings make up 23% of its $531M portfolio in Q2 2015.
  • Woodstock Corp opened 2 new positions and closed 7 in Q2 2015.
  • Woodstock Corp's portfolio value fell 1.5% quarter-over-quarter to $531M.

Based on Woodstock Corp's 13F filing for Q2 2015, filed 7 Jul 2015.